Papers
14
Total Citations
648
H-Index
11
About
Norman Williams is a prominent urological surgeon and clinical trialist whose research has profoundly shaped the evidence base for minimally invasive and robot-assisted urological surgery. His work spans bladder cancer, prostate cancer, and kidney cancer, with a particular focus on comparing robotic surgical approaches against established open techniques through rigorously designed randomised controlled trials. Williams is perhaps best known for leading the iROC trial, which generated landmark evidence on robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer — his 2022 publication has already amassed over 320 citations, reflecting its immediate and widespread influence on surgical practice. Complementing this, his 2023 cost-effectiveness analysis provided payers and health systems with critical economic data to guide adoption of robotic surgery. Equally significant is his leadership of the NeuroSAFE PROOF programme, investigating intraoperative frozen section analysis during robotic prostatectomy to better preserve nerve function and improve patients' postoperative erectile function and continence. His 2025 phase 3 trial represents a landmark contribution to quality-of-life outcomes in prostate cancer surgery. Williams has also pioneered innovative trial methodology, including cohort-embedded designs for small renal mass management through the NEST trial. Across all his work, Williams demonstrates an exceptional commitment to generating high-quality evidence that directly improves patient recovery and surgical decision-making.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10